Australia’s Victoria advances mRNA trials with $1.41m grants

Healthcare Asia Magazine website works best with Javascript enabled. Please enable your javascript and reload the page.

Projects supported by the programme include a lupus clinical trial and treatments for bone marrow failure syndrome that are moving closer to clinical trials. Medical Research Minister Anthony Carbines said the funding would support researchers developing vaccines and medicines.

What Happened

Burnet Institute Director and CEO Professor Brendan Crabb AC said investment in mRNA research helps move scientific discoveries into clinical trials. Our team can help you design and create an advertising campaign, in print and digital, on this website and in print.

• Published: 48 minutes ago Photo by Lucas Vasques via Unsplash Australia’s Victoria advances mRNA trials with $1.41m grants The programme has backed 65 projects with $23.9m in investment since 2021.

• Australia's Victoria government has allocated $1.41m (AU$2m) in grants to support messenger ribonucleic acid (mRNA) research projects aimed at advancing vaccines and medicines towards clinical trials.

• The funding comes under the mRNA Victoria Pipeline Program, which has supported 65 research projects with $23.9m (AU$34m) in investment since 2021.

Key Details

The Victorian government said it has invested more than $704.2m (AU$1b) in health and medical research over the past decade, supporting research activity, jobs, and medical breakthroughs.

• Let us help you drive your business forward with a good partnership!

• We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

• We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event.

What Reports Say

Coverage of the story so far points to:

• Continued reporting by Healthcare Asia Magazine as more details emerge